Document Detail


Candesartan cilexetil in hypertension: effects of six weeks' treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-aldosterone system.
MedLine Citation:
PMID:  10697305     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of the angiotensin II receptor blocker candesartan cilexetil on systemic and forearm haemodynamics and baroreceptor sensitivity were evaluated in this randomized, placebo-controlled, double-blind, crossover study. After a 4-week placebo run-in period, 22 patients with essential hypertension (diastolic blood pressure 100-114 mmHg) were randomized to receive either candesartan cilexetil 16 mg or placebo once daily for 6 weeks. At the end of each period, 24 h after the last dose, invasive haemodynamic assessments were performed. Simultaneously, the plasma renin activity and plasma concentrations of angiotensin II, aldosterone and catecholamines were measured. Compared to placebo, candesartan cilexetil significantly reduced mean arterial pressure by 8 mmHg (95% CI: 2.6; 12.3), while cardiac output, stroke volume and heart rate were unchanged. Forearm vascular resistance was reduced by 1 mmHg x ml(-1) x L x min (CI: 0.3; 2.3). The baroreceptor sensitivity was not influenced, but a change in the set-point was noted. Plasma renin activity and angiotensin II concentrations were increased, while the aldosterone concentration was significantly reduced. Plasma catecholamine concentrations were unaffected. In conclusion, 6 weeks' treatment with candesartan cilexetil 16 mg o.d. induced systemic and forearm vasodilatation and a reduction in blood pressure without compromising cardiac performance. The plasma concentration of aldosterone was reduced.
Authors:
K U Fridman; M Wysocki; P R Friberg; O K Andersson
Related Documents :
16522995 - Resistant or difficult-to-treat hypertension.
10661485 - Saline-resistant metabolic alkalosis, severe hypokalemia and hypertension in a 74-year-...
15229305 - Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
7960015 - Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.
21921085 - Relationship between late-life hypertension, blood pressure, and alzheimer's disease.
3436885 - Effects of hyperoxia on vasoconstriction and va/q matching in the neonatal lung.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Blood pressure     Volume:  8     ISSN:  0803-7051     ISO Abbreviation:  Blood Press.     Publication Date:  1999  
Date Detail:
Created Date:  2000-03-24     Completed Date:  2000-03-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9301454     Medline TA:  Blood Press     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  242-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. katarina.fridman@hassle.se.astra.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antihypertensive Agents / therapeutic use
Baroreflex / drug effects
Benzimidazoles / administration & dosage*
Biphenyl Compounds / administration & dosage*
Blood Pressure / drug effects
Cross-Over Studies
Double-Blind Method
Forearm / blood supply,  physiology
Hemodynamics / drug effects
Humans
Hypertension / drug therapy*
Middle Aged
Prodrugs / therapeutic use
Receptors, Angiotensin / antagonists & inhibitors
Renin-Angiotensin System / drug effects
Tetrazoles*
Time Factors
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Benzimidazoles; 0/Biphenyl Compounds; 0/Prodrugs; 0/Receptors, Angiotensin; 0/Tetrazoles; 145040-37-5/candesartan cilexetil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Similar central hemodynamics in salt-sensitive and salt-resistant hypertensive patients.
Next Document:  Health economics and orthopaedics.